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Evaluation of the Effectiveness of Mass
Screening for Uterine Cancer in Japan:
The Potential Years of Life Lost
by Tetsuo Kuroishi,* Kaoru Hirose,* and Suketami
Tominaga*
To evaluate the effectiveness of mass screening for uterine cancer in Japan, we compared the changes
in the age-adjusted rates of potential years of life lost (PYLL) due to uterine cancer between 1969 and
1972 to 1973 through 1977 between the high coverage-rate (intensively screened) areas and the comparable
control areas. The percent reduction in the average age-adjusted rate of PYLL due to uterine cancer and
the years oflife saved per 100,000 females were greater in the high coverage-rate areas than in the control
areas. These results suggested that mass screening programs for uterine cancer contribute to saving years
of life.
Introduction
InJapan a mass screeningprogram foruterine cancer
was started around 1960. A report published by the
Health Service Bureau of the Ministry of Health and
Welfare, Fourth Nationwide Survey onMalignant Neo-
plasms inJapan, carried out in 1979, revealed that mass
screening for uterine cancer had been conducted in
98.6% ofall the 3278 municipalities inJapan in 1978 (1).
Under the Health and Medical Services Law for the
Elderly, enacted in 1983, all municipalities had an ob-
ligation to conduct mass screening programs foruterine
cancer. This paper evaluates the effectiveness of mass
screening for uterine cancer.
The final goal of cancer control is preventing the dis-
ease. An immediate and attainable objective is to pre-
vent or delay cancer mortality and to increase the life
expectancy. Mass screening for cancer decreases life
shortening caused by cancer because screening permits
early cancer detection and prompt curative treatment.
The impact ofcancer mortality has usually been pre-
sented by the age-adjusted mortality rate. We previ-
ously attempted to evaluate the effectiveness of mass
screening programs for cancer in the population, using
the age-adjusted mortality rates (2-4). In this paper,
we also attempted to analyze whether or not the mass
screening programs foruterine cancerinJapan can con-
tribute to the decrease ofthe potential years oflife lost
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(PYLL) attributed to uterine cancer. The PYLL tends
to emphasize reduction in cancer mortality in younger
age groups, while the age-adjusted statistic counts
death at younger ages essentially the same as a death
at older ages.
Materials and Methods
Potential Years of Life Lost
The PYLL (5-8) is calculated based on the expected
remaining lifetime ofa person at the time ofdeath. We
calculated the years ofliferemainingupuntilthefemale
life expectancy of the mid-year of the study period in
Japan. The PYLL is given by:
PYLL = I ai di
where ai denotes the remaining years until female life
expectancy inJapan in 1973 (mid-year ofstudy period),
di denotes the number of deaths of age group i.
To compare the PYLLs betweenthe populations with
different size and different age structure, age-adjusted
rates must be used. Hence,
Age-adjusted rate of PYLL =
ai (N) >di ai(N)Pi
where Ni denotes the number of persons of age group
i of the standard population, Segi-Doll's world popula-
tion; N denotes the total number ofpersons ofthe stan-
dard population; ni denotes the number of persons ofKUROISHI, HIROSE, AND TOMINAGA
age group i ofthe actual population; and pi denotes the
age-specific death rate ofage group i from cancer ofthe
uterus in Japan.
Selection of the High Coverage-Rate Areas
for Uterine Cancer Mass Screening
Based on the information from the 1979 mass screen-
ing published in the Fourth Nationwide Survey on Ma-
lignant Neoplasms in Japan, we calculated the esti-
mated average coverage rates per year between 1969
and 1978 of women aged 30 to 69 years for all of the
3278 municipalities in Japan; we assumed all of the
women aged 30 to 69 years were screenees. From all
the 3278municipalities inJapan, 155municipalities hav-
ing an estimated average coverage rate of20% and over
were selected as so-called high coverage-rate areas (A
in Table 1).
From these high coverage-rate areas, we selected 58
municipalities that had age-adjusted rates ofPYLL due
to uterine cancer in 1969 to 1972 greater than 90% of
the average rate of PYLL (230.9 per 100,000 females)
of all Japanese (B in Table 1).
When high coverage-rate municipalities were limited
to the ones with the population size larger than 5000,
93 municipalities were selected (C in Table 1). Thirty-
six municipalities were selected that had the average
coverage rate of 20% and over. The age-adjusted rate
of PYLL due to uterine cancer in 1969 to 1972 was
greater than 90% of that ofJapan having a population
larger than 5000 (D in Table 1).
Selection of the Control Areas
In order to keep good comparability, two municipal-
ities were selected as controls. These corresponded to
each high coverage-rate municipality from those in the
Table 1. Selection of high coverage-rate areas for uterine cancer
mass screening.
Number ofhigh
coverage-rate
municipalities Conditions of selection
A 155 Estimated coverage ratea > 20%
B 58 Estimated coverage ratea > 20%
PYLL in 1969-1972b > 90%ofthe averagec
PYLL of all Japan
C 93 Estimated coverage rates > 20%
Population > 5000
D 36 Estimated coverage rate' > 20%
Population > 5000
PYLL in 1969_1972b > 90%ofthe averagec
PYLL of all Japan
Estimnated average coverage-rate per year in 1969 to 1978 of
women aged 30 to 69 years.
bThe age-adjusted rate of PYLL (potential years of life lost) per
100,000 females from uterine cancer in 1969 to 1972.
'The average age-adjusted rate of PYLL from uterine cancer in
Japan between 1969 and 1972 was 230.9/100,000 females.
same prefecture. These municipalities were matched by
population size, coverage rate of the national health
insurance, and age-adjusted rate ofPYLL due to uter-
ine cancer in 1969 to 1972.
Methods of Matching
We calculated a kind of distance (S) from each high
coverage-rate municipality to the all other municipali-
ties in the same prefecture, using community variates
as the following formula:
(X, -
2 (X2 - X02)2 (X3 -X3)2
SD~~~ SD2 SD2
where the first term of the right-hand side of this for-
mula is the one concerned with age-adjusted rate of
PYLL due to uterine cancer in 1969-1972. The second
term is the one concerned with population size, and the
third term is the one concerned with coverage-rate of
the national health insurance, a socio-occupational in-
dex. Three values, Xo1, X02, and X03, denote values of
the high coverage-rate municipality, and X1, X2 and X3
denote values of the candidate municipality as control;
SD1, SD2 and SD3 denote standard deviations for all
municipalities in Japan; and W1, W2 and W3 denote
weights proportional to the F-values for partial regres-
sion coefficients in the multiple regression analysis,
where change oftherate ofPYLL dueto uterine cancer
was regressed on these three most important adjusting
factors.
Assuming that the municipality with the minimum
distance (S) from each high coverage-rate municipality
is the best matched control municipality, two munici-
palities with the smallest and the second smallest dis-
tance (S) were selected as controls.
95% Confidence Interval of the Change in
PYLL
Based on the vital statistics from the Ministry of
Health and Welfare, we calculated the age-adjusted
rates ofPYLL due to uterine cancer between 1969 and
1972 and between 1973 and 1977 and their changes by
municipality across Japan.
Ageneralmethod forinterval estimationisto assume
that some transform ofthe parameter follows a normal
distribution (9). For the present study, the logarithmic
transformation of the ratio of PYLL was used. Let Z
= log(r2/r1) where r2 is the age-adjusted rate ofPYLL
in 1973 to 1977, and r1 is the one in 1969 to 1972. Then
2
V = Var(z) = E [a2iNi2wji(1 - uji)lnjil jN i=1
CL1,CLu(r2/r1 - 1) = exp(Zo + 1.96\/V) - 1
CL1 and CLu are the lower/upper confidence limits.
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Results
To evaluate the effectiveness of mass screening for
uterine cancer, we compared the changes in the age-
adjusted rates ofPYLL due to uterine cancerfrom 1969
to 1972 and from 1973 to 1977 between the overall high
coverage-rate areas and the overall comparable control
areas.
In the 155 high coverage-rate (20% and over) areas
(AinTable 1), the percentreduction ofthe average age-
adjusted rate of PYLL due to uterine cancer (34.6%)
was greater than that (22.3%) in the 310 control areas
(statistically not significant at the 5% level). The years
oflife saved per 100,000 females was 69.6 person-years
in the high coverage-rate areas, and greater than that
(48.5 person-years) in the control areas (Table 2). The
screeningrate foruterine cancer was 25.4% amonghigh
coverage-rate areas and 9.1% amongcontrol areas. The
changes in age-specific death rate, the changes in
PYLL, and the percent changes in PYLL by5-year age
groups from cancer of the uterus from 1969-1972 to
1973-1977 among the high coverage-rate areas were
comparedwiththose amongthecontrol areas. Generally
spealdng, the years of life saved per 100,000 females
and the percent reduction in PYLL were greater in the
high coverage-rate areas than in the control areas, es-
pecially in younger age groups (Table 3).
When the high coverage-rate areas were limited to
those with the age-adjusted rate of PYLL due to the
uterine cancer in 1969-1972 were greater than 90% of
the average rate of PYLL of all Japan (Table 1), the
years of life saved and the percent decrease in the av-
erage age-adjusted rate of PYLL from cancer of the
uterus were also greater in these high coverage-rate
areas (271.9 person-years and69.9%)thaninthe control
areas (125.4 person-years and 39.5%) (p < 0.05) (Table
4). The average coverage-rate ofuterine cancer screen-
ing for high coverage-rate areas was 25.2% and that of
the control areas was 8.7%. The years oflife saved per
100,000 females and the percent decrease in PYLL by
5-year age groups were generally greater in the high
coverage-rate areasthaninthe control areas, especially
in younger age groups (Table 5).
When the high coverage-rate areas were limited to
municipalities with the population size larger than 5000
(Table 1) inordertoreducetherandomvariationofrate
of PYLL due to small size of population, the similar
trends were observed (Tables 6 and 7).
Discussion
Randomized controlled trial is considered to be the
most accurate or most convincing method to evaluate
the effectiveness ofmass screening for cancer because
itisfreeofsomebiases, suchasself-selectionbias, lead-
time bias, and length bias. Individual allocation method
was used in the Health Insurance Plan ofGreater New
York (HIP) study for breast cancer screening (10) or
the Mayo Lung Project for lung cancer screening (11).
Group/areas allocation method was used in Swedish
study on mass screening for breast cancer (12).
It is difficult to conduct these trials, as shown by the
factthat only afewrandomized trials forcancerscreen-
ing have been conducted throughout the world. In Ja-
pan, no randomized trials of mass screening for any
cancer have been conducted. Consequently, the effec-
tiveness ofmass screeningfor cancerinJapan has been
studied by several alternative methods ofarandomized
trial, i.e., observational studies [time trend analysis
(13-15)], or case-control studies (16). There have been
a few studies on the effectiveness of uterine cancer
screening in Japan. We tried to compare the trends in
the age-adjusted mortality rate from cancer of the
uterus for municipalities with intensively screened
women (so-called high coverage-rate areas) with those
for matched control municipalities (2-4).
The final objective of cancer control is to prevent
cancer, but currently it seems impossible to completely
eliminate cancer as a cause of death. Our attainable
objective of mass screening for cancer as a secondary
prevention is to prevent or delay cancer mortality and
decrease the life shortening due to cancer. As we prog-
ress toward this objective, we will gradually shift the
age-specific death rate curves to the right (older side).
Therefore, we should evaluate screening programs on
thebasisofwhethertheydecreasetheage-specificmor-
tality rates, especially at younger ages, and increase
the life expectancy. In the present paper, using the
PYLL we also attempted to see whether or not mass
screening programs for uterine cancer in Japan could
Table 2. Comparisons ofthe age-adjusted rates of potential years of life lost (PYLL) due to uterine cancer and their changes between
the high coverage-rate areas (A in Table 1) and the control areas.
Age-adjusted rate
ofPYLL per
100,000 females
1969-72 1973-77
201.1 131.5
217.6 169.1
Years of
life lost
-69.6
-48.5
Change in
PYLL,
%e
-34.6
-22.3
95% confidence
interval,
-46.4/-20.3
-28.81-15.2
Coverage
ratea
H
C
Number of
municipalities
155
310
Coverage rate
ofscreening
1969-78,
%b
25.4
9.1
aH, high coverage rate areas; C, control areas.
bAverage weighted byfemales aged 30 to 69 years.
'Change = [(r2 - rl)/r1] x 100%; rl, age-adjusted rate ofPYLL due to uterine cancer in 1969-72; r2, age-adjusted rate of PYLL due to
uterine cancer in 1973-77.
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Table 3. Comparisons of the age-specific, age-adjusted death rates, change in PYLL from uterine cancer and their changes between
the high coverage-rate areas (A in Table 1) and the control areas.
High coverage-rate areas Control areas
(155 municipalities) (310 municipalities)
Death rate per Difference Difference Death rate per Difference Difference
Age 10,00 women in in % Change 10,0 women in in % Change
groups 1969-72 1973-77 death rate PYLLa in PYLL 1969-72 1973-77 death rate PYLLa in PYLL
25-29 1.67 0.60 - 1.07 - 53.84 - 64.3 1.07 1.00 - 0.07 - 3.8 - 7.0
30-34 4.93 0.68 - 4.25 - 192.50 - 86.2 1.89 1.90 0.01 0.4 0.5
35-39 2.37 1.15 - 1.22 - 49.28 -51.4 5.41 3.43 - 1.98 - 80.4 -36.7
40-44 4.03 3.41 - 0.61 - 21.91 -15.2 10.83 6.62 - 4.21 - 150.5 -38.9
45-49 22.21 9.88 -12.33 - 384.13 - 55.5 15.98 14.57 - 1.42 - 44.1 - 8.9
50-54 26.08 15.92 - 10.16 -270.72 -39.0 26.17 20.02 - 6.15 - 163.8 -23.5
55-59 30.16 25.67 - 4.49 -100.12 -14.9 32.26 23.15 - 9.10 -202.9 -28.2
60-64 36.85 29.20 - 7.65 - 138.50 -20.8 46.78 34.83 - 11.95 -216.3 -25.6
65-69 47.40 34.88 - 12.52 - 177.83 -26.4 48.93 40.97 - 7.96 - 113.0 - 16.3
70-74 46.19 49.11 2.92 31.22 6.3 62.69 50.70 - 11.99 - 128.2 - 19.1
75-79 60.76 46.58 - 14.18 - 109.46 -23.3 69.20 71.56 2.36 18.2 3.4
80-84 58.94 40.11 - 18.83 - 102.65 -32.0 54.72 68.80 14.08 76.7 25.7
Age-adjusted rate
30-69b 18.55 12.36 - 6.19 -168.2 19.67 14.80 - 4.87 -112.1
All ages 9.48 6.84 - 2.64 - 69.6 10.58 8.52 - 2.06 - 48.5
Average
coverage-rate 25.4% 9.1%
of screeningc
aPotential years oflife lost (PYLL)/100,000 women.
bTruncated age-adjusted rate/100,000 women from uterine cancer which is standardized on the age distribution of the Segi-Doll's world
population.
cEstimated average coverage-rate/year between 1969 and 1978 of women aged 30 to 69 years.
Table 4. Comparisons of the age-adjusted rates ofpotential years of life lost (PYLL) due to uterine cancer and their changes between
the high coverage-rate areas (B in Table 1) and the control areas.
Number of
municipalties
58
116
Coverage rate
of screening
1969-78,
%b
25.2
8.7
Age-adjusted rate
of PYLL per
100,000 females
1969-72
388.8
317.3
1973-77
116.9
191.9
Years of
life lost
-271.9
- 125.4
Change in
PYLL,
%C
-69.9
-39.5
95% confidence
interval,
- 77.4/-60.0
- 45.5/- 32.9
aH, high coverage rate areas; C, control areas.
bAverage weighted by females aged 30 to 69 years.
'Change = [(r2
-r,)/r,] x 100%; r,, age-adjusted rate of PYLL due to uterine cancer in 1969-72; r2, age-adjusted rate of PYLL due to
uterine cancer in 1973-77.
contribute to the delay of death from this cancer or to
the increase oflife expectancy, which tend toemphasize
reduction in cancer mortality in younger age groups.
Generally speaking, higher coverage rates of mass
screening tended to be observed in municipalities with
small population size. In the present study, the munic-
ipalities with high coverage rates ofscreening also had
relatively smallpopulation sizes, andhencethe so-called
regression toward the mean phenomena may occur be-
cause of the random variation of rate of PYLL due to
uterine cancer and also because ofthe small size of pop-
ulation. So, the higher the rate of PYLL in the former
period, the steeper it may tend to decrease. This is the
reason why the rate of PYLL from uterine cancer in
the former period (in 1969 to 1972) should be matched.
In addition, other factors such as population size and
coverage rate of the national health insurance should
also be matched from the aspects ofthe medical service,
industrial structure, and otherfactors. We selected con-
trol municipalities from the same prefecture of corre-
sponding high coverage-rate municipalities to secure
the similarity of natural, geographical, or social envi-
ronment.
The previously mentioned high coverage-rate areas
(A or C in Table 1) may have included a large number
ofmunicipalities that haverelatively low rates ofPYLL
due to uterine cancer between 1969 and 1972. The low
rates could be partly due to the effects ofprevious mass
screening for uterine cancer and partly due to random
variation of rates of PYLL because of the small popu-
lation in these relevant municipalities.
Ifthese concomitant effects were excluded, we could
clarify the effectiveness of mass screening for uterine
cancer. Thus, we tried to limit our study to only the
municipalities with the age-adjusted rates of PYLL
from uterine cancer between 1969 and 1972. These mu-
Coverage
ratea
H
C
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Table 5. Comparisons of the age-specific, age-adjusted death rates, change in PYLL from uterine cancer and their changes between
the high coverage-rate areas (B in Table 1) and the control areas.
High coverage-rate areas Control areas
(58 municipalities) (116 municipalities)
Death rte per Difference Difference Dahrt e Difference Difference
Age 100,000 women in in % Change 100,000 women inin % Change
groups 1969-72 1973-77 death rate PYLLa in PYLL 1969-72 1973-77 death rate PYLL in PYLL
25-29 4.41 0.00 - 4.41 -220.8 -100.0 1.81 1.02 - 0.78 - 39.2 -43.3
30-34 13.24 0.00 -13.24 - 599.6 -100.0 2.77 1.43 - 1.35 - 61.0 -48.6
35-39 6.31 1.53 - 4.78 -193.5 - 75.7 8.65 3.80 - 4.85 -196.5 -56.1
40-44 4.73 1.31 - 3.42 -122.3 - 72.3 16.83 7.86 - 8.98 -321.2 -53.3
45-49 41.12 9.03 -32.09 -999.7 - 78.1 24.67 17.18 - 7.49 -233.3 -30.4
50-54 56.97 19.91 -37.06 -987.3 - 65.1 38.94 22.78 -16.16 -430.4 -41.5
55-59 55.40 27.35 -28.06 -625.1 - 50.6 47.65 27.43 -20.22 -450.5 -42.4
60-64 75.36 22.26 -53.09 -961.0 - 70.5 64.87 40.15 -24.72 -447.5 -38.1
65-69 69.19 15.57 -53.62 -761.4 - 77.5 65.63 48.62 -17.01 -241.5 -25.9
70-74 57.50 65.77 8.27 88.5 14.4 83.02 48.21 -34.80 -372.0 -41.9
75-79 117.56 46.35 -71.21 -549.8 - 60.6 83.56 78.29 - 5.27 - 40.7 - 6.3
80-84 62.16 49.37 -12.80 - 69.8 - 20.6 54.85 72.65 17.80 97.0 32.5
Age-adjusted rate
30-69" 35.20 10.40 -24.80 -626.4 28.98 17.79 -11.19 -283.5
All ages 17.17 6.37 -10.80 -271.9 14.87 9.57 - 5.30 -125.4
Average
coverage-rate 25.2% 8.7%
of screeningc
aPotential years oflife lost (PYLL)/100,000 women.
'Truncated age-adjusted rate/100,000 women from uterine cancer which is standardized on the age distribution of the Segi-Doll's world
population.
cEstimated average coverage rate/year between 1969 and 1978 ofwomen aged 30 to 69 years.
Table 6. Comparisons ofthe age-adjusted rates ofpotential years of life lost (PYLL) due to uterine cancer and their changes between
the high coverage-rate areas (C in Table 1) and the control areas.
Number of
municipalities
93
186
Coverage rate
of screening
1969-78,
%b
25.0
9.1
Age-adjusted rate
of PYLL per
100,000 females
1969-72 1973-77
204.2 128.1
208.1 160.4
Years of
life lost
-76.1
-47.7
Change in
PYLL,
%c
-37.3
-22.9
95% confidence
interval,
-49.5/-22.0
-30.7/-14.2
aH, high coverage rate areas; C, control areas.
bAverage weighted by females aged 30 to 69 years.
'Change = [(r2 -rl)/r1] x 100%; r,, age-adjusted rate of PYLL due to uterine cancer in 1969-72; r2, age-adjusted rate ofPYLL due to
uterine cancer in 1973-77.
Table 7. Comparisons of the age-adjusted rates of potential years of life lost (PYLL) due to uterine cancer and their changes between
the high coverage-rate areas (D in Table 1) and the control areas.
Number of
municipalities
36
72
Coverage rate
ofscreening
1969-78,
%b
25.0
9.0
Age-adjusted rate
ofPYLL per
100,000 females
1969-72
367.6
295.0
1973-77
125.4
178.8
Years of
life lost
-242.1
- 116.2
Change in
PYLL,
%c
-65.9
-39.4
95% confidence
interval,
-75.1/-53.1
-47.0/-30.6
aH, high coverage rate areas; C, control areas.
"Average weighted by females aged 30 to 69 years.
'Change = [(r2
-rl)/r,] x 100%; r1, age-adjusted rate of PYLL due to uterine cancer in 1969-72; r2, age-adjusted rate of PYLL due to
uterine cancer in 1973-77.
nicipalities had rates greater than 90% of the average
rate of PYLL (230.9 person-years per 100,000 women)
ofallJapan (B orD inTable 1). This 90% level, although
somewhatarbitrary, wasused toinclude adequate num-
bers of municipalities in the analysis. These analyses
demonstrated a significant reduction of PYLL due to
uterine cancer in high coverage-rate areas. Factors
other than mass screening, such as the decrease in the
Coverage
ratea
H
C
Coverage
ratea
H
C
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incidence from uterine cancer might contribute to the
reduction in PYLL, but such data were not available.
So we could not definitely claim a reduction of PYLL,
but these results suggested that mass screening pro-
grams for uterine cancer may be possible to save the
years of life because ofthis cancer.
The PYLL tends to lay weight on the reduction in
cancermortalityinyoungeragegroups. Massscreening
programs for cancer should be able to prevent or delay
cancer deaths, and then to increase life expectancy.
From the present study, it was suggested the PYLL
was one of the appropriate indices in evaluating the
impact ofmass screening for cancer.
We express our thanks to the Ministry of Health and Welfare for
permission to use the materials from the Fourth Nationwide Survey
on Malignant Neoplasms.
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